Roles
- Associate Professor of Clinical Dermatology and Cutaneous Surgery
-
Education & Training
Education
-
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Hope for Patients with Hidradenitis Suppurativa
Dermatology Research Team Investigating the Most Common Disease You’ve Never Heard About
Treating a Life-Altering Skin Disease
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 26 clinical trials.
-
The purpose of the trial is to learn more about the safety and effects of remibrutinib in the long-term treatment of adult patients with HS who have completed either of the preceding Phase 3 clinical trials, CLOU064J12301 or CLOU064J12302.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Open
-
The purpose of this study (HS0006) is to assess the pharmacokinetics (PK) and safety of bimekizumab in adolescents (12 to <18 years of age) and children 9 years of age with moderate to severe hidradenitis suppurativa (HS) and who are at Tanner stage 2 or more ofpubertal development.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Not Accepting
-
The purpose of this study is to continue assessing long-term safety across inflammatory conditions in which povorcitinib is being evaluated.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Open
-
To establish the efficacy of ruxolitinib 1.5% cream BID in participants with HS.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Not Accepting
-
The purpose of this study is to determine if the study drug, sonelokimab, is safe and well tolerated over 24 weeks of treatment in adolescents with moderate to severe HS.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Not Accepting
-
To demonstrate the efficacy of sonelokimab compared with placebo with respect to HiSCR75 over 16 weeks of treatment in participants with moderate to severe HS.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Closed
-
The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) 10 mg b.i.d. and 25 mg b.i.d. compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Not Accepting
-
To evaluate the long-term safety of povorcitinib.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Not Accepting
-
To test if eltrekibart is superior to placebo in inducing Hidradenitis Suppurativa Clinical Response (HiSCR50) in adult participants with moderate-to-severe HS
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Closed
-
We will characterize the challenges to physical activity and exercise for HS patients and design an EP with evidence-based techniques and examine its outcome.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Open
-
The purpose of this study is to compare the safety and effects of INCB054707 with placebo in people with hidradenitis suppurativa.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Closed
-
Phase 2, Randomized, Parallel-group, Double-blind, Placebo-controlled Study of Sonelokimab in Patients With Active Moderate to Severe Hidradenitis Suppurativa
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 2
- Enrollment Status: Closed
-
An Open Label, Multiple Ascending Dose Study of the Safety, Tolerability and Bio-effect of Aurase for Wound Debridement in Patients With Venous Leg Ulcers.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 2
- Enrollment Status: Closed
-
The Effect of Inelastic Compression System on Quality of Life in People With Chronic Venous Insufficiency
- Principal Investigator: Hadar Lev-Tov
- Study Phase: N/A
- Enrollment Status: Closed
-
A Bioelectric Dressing for Post De-Roofing Treatment of Hidradenitis Suppurativa (HS)
- Principal Investigator: Hadar Lev-Tov
- Study Phase: N/A
- Enrollment Status: Closed
-
A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 3
- Enrollment Status: Closed
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 2
- Enrollment Status: Closed
-
The purpose of this protocol is to verify and validate an exudate assessment technique for the determination of wound status and prediction of healing trajectory in chronic wounds.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: N/A
- Enrollment Status: Closed
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 3
- Enrollment Status: Closed
-
A Multicenter Phase 3 Trial of Biotherapy Using Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 3
- Enrollment Status: Closed
-
An Exploratory, Single Center, Observer Masked, Active Control, Randomized Trial to Investigate the Effectiveness of Dialkylcarbomoyl Chloride Dressing (Cutimed Sorbact) in Modifying Bacterial Load in Venous Leg Ulcers (VLU)
- Principal Investigator: Hadar Lev-Tov
- Study Phase: N/A
- Enrollment Status: Closed
-
Autologous Regeneration of Tissue (ART) for Wound Healing
- Principal Investigator: Hadar Lev-Tov
- Study Phase: N/A
- Enrollment Status: Closed
-
To evaluate the long-term safety and tolerability of sonelokimab in participants with moderate to severe HS
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase III
- Enrollment Status: Not Accepting
-
A Multicenter, Double-blind, Randomized Withdrawal Extension Study of Subcutaneous Secukinumab to Demonstrate Long-term Efficacy, Safety and Tolerability in Subjects With Moderate to Severe Hidradenitis Suppurativa
- Principal Investigator: Hadar Lev-Tov
- Study Phase: Phase 3
- Enrollment Status: Closed
-
The purpose of this research is to evaluate the performance and safety of the ALLEVYN Non-Adhesive dressing in managing chronic wounds.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Closed
-
The purpose of this research is to evaluate the performance and safety of the Mepilex Up dressing in managing chronic wounds.
- Principal Investigator: Hadar Lev-Tov
- Study Phase: TBD
- Enrollment Status: Closed